What does Magis-Pharma do?
FAC SECUNDUM ARTEM specializes in providing high-quality training and consultancy services in the field of arts and culture. The company focuses on enhancing skills and knowledge for individuals and organizations through workshops and tailored programs. Their mission is to empower creativity and foster a deeper appreciation for the arts.
- Sectors
- Consultancy firms Wholesalers
- Signals
-
Reporting lossesReporting losses € -374K
The company reported a loss in the latest financial year.
Strong equityStrong equity € 248KStrong equity provides a buffer against setbacks.
Positive cashflowPositive cashflow € 313KPositive operating cash flow in the latest financial year.
Positive EBITDAPositive EBITDA € 783KPositive EBITDA: operating activities are profitable.
High turnoverHigh turnover € 14.70MSubstantial turnover in the latest financial year.
Healthy social debtHealthy social debt 10.2%Social debts stay manageable relative to personnel costs.
- Shareholders
- Magis Pharma 100%, Magis Pharma Group 100%
Financial ratios
|
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
€
14.70M
|
€
14.10M
|
€
12.16M
|
€
11.98M
|
|
|
€
783K
|
€
-497K
|
€
101K
|
€
352K
|
|
|
€
-374K
|
€
-1.46M
|
€
-275K
|
€
36K
|
|
|
€
248K
|
€
622K
|
€
1.79M
|
€
2.06M
|
|
|
1.98%
|
5.36%
|
23.71%
|
38.60%
|
|
|
€
12.30M
|
€
10.98M
|
€
5.75M
|
€
3.28M
|
|
|
€
93K
|
€
777K
|
€
470K
|
€
101K
|
|
|
53.30
|
50.40
|
17.90
|
13.40
|
Publications 22
All publications- Ontslagen - Benoemingen 21/10/2026
- Kapitaal - Aandelen - Rubriek Herstructurering (Fusie, Splitsing, Overdracht Vermogen, Enz...) 08/09/2026
- Rubriek Herstructurering (Fusie, Splitsing, Overdracht Vermogen, Enz...) 23/06/2026
- Ontslagen - Benoemingen - Statuten (Vertaling, Co?Rdinatie, Overige Wijzigingen, ?) 05/06/2026
- Ontslagen - Benoemingen 26/11/2025
Frequently asked questions
Answers to the most common questions about Magis-Pharma, based on official government data and the filed annual accounts.
What is the VAT number of Magis-Pharma?
The VAT number of Magis-Pharma is BE0644.784.239.
How many employees work at Magis-Pharma?
In 2025, Magis-Pharma employed 53.30 full-time equivalents (FTE).
When was Magis-Pharma established?
Magis-Pharma was founded in 22-12-2015.
What is the official address of Magis-Pharma?
The official address of Magis-Pharma is Neerlandweg 24 Antwerpen 2610.
What is the legal form of Magis-Pharma?
The juridical form of Magis-Pharma is Public limited company (NV/SA).
What is the annual revenue of Magis-Pharma?
The revenue of Magis-Pharma for the 2025 financial year was €14,703,063.
What does Magis-Pharma do?
FAC SECUNDUM ARTEM specializes in providing high-quality training and consultancy services in the field of arts and culture. The company focuses on enhancing skills and knowledge for individuals and organizations through workshops and tailored programs. Their mission is to empower creativity and foster a deeper appreciation for the arts.
Is Magis-Pharma a reliable company?
Magis-Pharma is a registered Rechtspersoon with company number 0644.784.239 and can be verified through the official CBE database.
What is the credit limit of Magis-Pharma?
The estimated credit limit of Magis-Pharma is €1,130,302.
Is Magis-Pharma still active?
Magis-Pharma currently has the status "Normal situation" and is active.